NavigAID SSc Assay Diagnoses Scleroderma Subgroups, Could Lead to New Therapies
Protagen has launched NavigAID SSc, a new disease stratification assay that, by measuring serum biomarkers, can define specific systemic sclerosis (SSc) patient subgroups, thereby facilitating differential diagnosis and supporting the development of personalized therapeutics in SSc. SSc is an autoimmune disorder in which the immune system attacks the body. The condition…